NSE BSE
kwality pharmaceuticals limite stock

Kwality Pharmaceuticals Limite Share Price

- - (%)
Sector: -

539997

KPL

img img img img
No Data Available

Kwality Pharmaceuticals Limite Share Price Update


As of the latest trading session, Kwality Pharmaceuticals Limite share price is currently at 511, which is up by 1.89 from its previous closing. Today, the stock has fluctuated between 500.00 and 511.00. Over the past year, Kwality Pharmaceuticals Limite has achieved a return of 64.99 %. In the last month alone, the return has been 13.37 %.

Kwality Pharmaceuticals Limite Performance

Day Range

Low500.00 High511.00
508.00

52 Week Range

Low 248.00 High 545.00
508.00

Open Price

508.00

Prev. Close

509.10

Volume (Shares)

9827.00

Total traded value

49.92

Upper Circuit

532.10

Lower Circuit

481.50

Note: The current prices & values are delayed, Login to your account for live updates.

Kwality Pharmaceuticals Limite Fundamentals


(Standalone)

Market Cap (Cr) 530.22
PE Ratio (TTM) 43.85
Book Value / Share 205.12
Beta 0.56
ROE 16.56%
EPS (TTM) 27.38
Dividend Yield 0.00%
Net Profit Qtr (Cr) 7.70

Kwality Pharmaceuticals Limite Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 78.10
Operating Expense 68.93
Net Profit 7.70
Net Profit Margin (%) 9.85
Earnings Per Share (EPS) 7.42
EBITDA 17.32
Effective Tax Rate (%) 21.16
Particulars SEP 2023 (Values in Cr)
Revenue 69.65
Operating Expense 61.67
Net Profit 6.26
Net Profit Margin (%) 8.98
Earnings Per Share (EPS) 6.03
EBITDA 15.50
Effective Tax Rate (%) 23.75
Particulars JUN 2023 (Values in Cr)
Revenue 67.45
Operating Expense 60.61
Net Profit 5.45
Net Profit Margin (%) 8.08
Earnings Per Share (EPS) 5.17
EBITDA 14.21
Effective Tax Rate (%) 24.72
Particulars MAR 2023 (Values in Cr)
Revenue 68.80
Operating Expense 63.37
Net Profit -7.36
Net Profit Margin (%) -10.69
Earnings Per Share (EPS) -7.15
EBITDA -3.55
Effective Tax Rate (%) 23.65
Particulars DEC 2022 (Values in Cr)
Revenue 56.01
Operating Expense 46.33
Net Profit 7.23
Net Profit Margin (%) 12.90
Earnings Per Share (EPS) 6.92
EBITDA 15.52
Effective Tax Rate (%) 27.91
Particulars MAR 2023 (Values in Cr)
Revenue 250.99
Operating Expense 211.64
Net Profit 19.47
Net Profit Margin (%) 7.75
Earnings Per Share (EPS) 18.45
EBITDA 46.70
Effective Tax Rate (%) 24.41
Particulars MAR 2022 (Values in Cr)
Revenue 456.13
Operating Expense 297.97
Net Profit 120.05
Net Profit Margin (%) 26.31
Earnings Per Share (EPS) 115.70
EBITDA 175.22
Effective Tax Rate (%) 25.74
Particulars MAR 2021 (Values in Cr)
Revenue 261.50
Operating Expense 241.29
Net Profit 15.42
Net Profit Margin (%) 5.89
Earnings Per Share (EPS) 14.86
EBITDA 30.85
Effective Tax Rate (%) 29.26
Particulars MAR 2020 (Values in Cr)
Revenue 138.68
Operating Expense 131.47
Net Profit 8.43
Net Profit Margin (%) 6.07
Earnings Per Share (EPS) 8.13
EBITDA 18.03
Effective Tax Rate (%) 24.32
Particulars MAR 2019 (Values in Cr)
Revenue 165.15
Operating Expense 155.18
Net Profit 7.55
Net Profit Margin (%) 4.57
Earnings Per Share (EPS) 7.27
EBITDA 16.16
Effective Tax Rate (%) 30.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.48
ROE % 16.57
ROCE % 18.50
Total Debt to Total Equity 0.38
EBITDA Margin 25.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 173.81
ROE % 99.66
ROCE % 94.93
Total Debt to Total Equity 0.40
EBITDA Margin 38.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.16
ROE % 28.21
ROCE % 23.78
Total Debt to Total Equity 0.72
EBITDA Margin 11.62
Particulars MAR 2020 (Values in Cr)
Book Value / Share 43.57
ROE % 20.10
ROCE % 17.26
Total Debt to Total Equity 0.78
EBITDA Margin 12.83
Particulars MAR 2019 (Values in Cr)
Book Value / Share 35.18
ROE % 23.10
ROCE % 21.69
Total Debt to Total Equity 0.84
EBITDA Margin 9.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 193.93
ROE % 16.56
ROCE % 18.47
Total Debt to Total Equity 0.38
EBITDA Margin 25.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 175.17
ROE % 98.62
ROCE % 94.24
Total Debt to Total Equity 0.39
EBITDA Margin 38.42
Particulars MAR 2021 (Values in Cr)
Book Value / Share 59.47
ROE % 28.55
ROCE % 23.96
Total Debt to Total Equity 0.71
EBITDA Margin 11.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share 44.62
ROE % 20.03
ROCE % 17.33
Total Debt to Total Equity 0.75
EBITDA Margin 13.02
Particulars MAR 2019 (Values in Cr)
Book Value / Share 36.49
ROE % 22.14
ROCE % 21.29
Total Debt to Total Equity 0.79
EBITDA Margin 9.79
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.36
Total Assets 353.63
Total Liabilities 353.63
Total Equity 199.06
Share Outstanding 10376198
Price to Book Ratio 1.59
Return on Assets (%) 5.47
Return on Capital (%) 6.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.95
Total Assets 340.59
Total Liabilities 340.59
Total Equity 179.78
Share Outstanding 10376198
Price to Book Ratio 3.31
Return on Assets (%) 35.23
Return on Capital (%) 51.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.80
Total Assets 166.26
Total Liabilities 166.26
Total Equity 59.85
Share Outstanding 10376198
Price to Book Ratio 0.94
Return on Assets (%) 9.10
Return on Capital (%) 16.02
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.53
Total Assets 132.69
Total Liabilities 132.69
Total Equity 44.96
Share Outstanding 10376198
Price to Book Ratio 0.57
Return on Assets (%) 6.26
Return on Capital (%) 10.89
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 105.38
Total Liabilities 105.38
Total Equity 36.31
Share Outstanding 10376198
Price to Book Ratio 1.02
Return on Assets (%) 7.16
Return on Capital (%) 12.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.09
Total Assets 356.58
Total Liabilities 356.58
Total Equity 202.02
Share Outstanding 10376198
Price to Book Ratio 1.59
Return on Assets (%) 5.45
Return on Capital (%) 6.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 342.67
Total Liabilities 342.67
Total Equity 182.55
Share Outstanding 10376198
Price to Book Ratio 3.31
Return on Assets (%) 35.03
Return on Capital (%) 50.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.13
Total Assets 168.78
Total Liabilities 168.78
Total Equity 62.50
Share Outstanding 10376198
Price to Book Ratio 0.94
Return on Assets (%) 9.13
Return on Capital (%) 15.85
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 134.68
Total Liabilities 134.68
Total Equity 47.09
Share Outstanding 10376198
Price to Book Ratio 0.57
Return on Assets (%) 6.26
Return on Capital (%) 10.74
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 106.99
Total Liabilities 106.99
Total Equity 38.66
Share Outstanding 10376198
Price to Book Ratio 1.02
Return on Assets (%) 7.05
Return on Capital (%) 11.72
Particulars MAR 2023 (Values in Cr)
Net Income 25.57
Cash from Operations 47.53
Cash from Investing -48.44
Cash from Financing 0.99
Net change in Cash -6.06
Free Cash Flow 95.21
Particulars MAR 2022 (Values in Cr)
Net Income 161.56
Cash from Operations 101.95
Cash from Investing -62.92
Cash from Financing 5.65
Net change in Cash 3.32
Free Cash Flow 157.10
Particulars MAR 2021 (Values in Cr)
Net Income 21.27
Cash from Operations 33.08
Cash from Investing -23.20
Cash from Financing 0.76
Net change in Cash 4.27
Free Cash Flow 56.48
Particulars MAR 2020 (Values in Cr)
Net Income 10.91
Cash from Operations 8.87
Cash from Investing -17.79
Cash from Financing 11.77
Net change in Cash 0.13
Free Cash Flow 29.65
Particulars MAR 2019 (Values in Cr)
Net Income 10.91
Cash from Operations 17.01
Cash from Investing -11.78
Cash from Financing -2.00
Net change in Cash -0.20
Free Cash Flow 28.83
Particulars MAR 2023 (Values in Cr)
Net Income 25.76
Cash from Operations 48.34
Cash from Investing -48.44
Cash from Financing 0.99
Net change in Cash -5.25
Free Cash Flow 96.01
Particulars MAR 2022 (Values in Cr)
Net Income 161.67
Cash from Operations 100.59
Cash from Investing -62.97
Cash from Financing 5.65
Net change in Cash 1.92
Free Cash Flow 155.75
Particulars MAR 2021 (Values in Cr)
Net Income 21.79
Cash from Operations 32.73
Cash from Investing -23.19
Cash from Financing 0.82
Net change in Cash 3.98
Free Cash Flow 56.13
Particulars MAR 2020 (Values in Cr)
Net Income 11.14
Cash from Operations 8.34
Cash from Investing -17.12
Cash from Financing 12.35
Net change in Cash 0.86
Free Cash Flow 29.08
Particulars MAR 2019 (Values in Cr)
Net Income 10.89
Cash from Operations 16.40
Cash from Investing -11.80
Cash from Financing -1.91
Net change in Cash -0.75
Free Cash Flow 28.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
Kwality Pharmaceuticals Limite 509.10 18.64 2.50 528.25 248.00 / 545.00
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
Kwality Pharmaceuticals Limite 509.10 18.59 2.48 528.25 248.00 / 545.00
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 506.70
  • 26 Days 491.90
  • 10 Days 502.90
  • 50 Days 487.30
  • 12 Days 503.00
  • 100 Days 459.70
  • 20 Days 494.30
  • 200 Days 354.30
512.37
PIVOT
First Resistance 516.73
Second Resistance 524.37
Third Resistance 528.73
First Support 504.73
Second Support 500.37
Third Support 492.73
RSI 51.62
MACD 11.12
Commodity Channel Index (CCI) 103.30
ADX 30.35
Williams % R -32.11

Over 1 Month

down

13.37

Over 3 Months

down

-1.57

Over 6 Months

down

49.42

Over 1 Year

down

64.99

Over 3 Years

down

73.16

Over 5 Years

down

69.86

Kwality Pharmaceuticals Limite Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Kwality Pharmaceuticals Limite Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
45.17
Promoter Holdings
54.82
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ramesh Arora Shareholding of Promoter and Promoter Group 2698684.0 26.01
Ajay Arora Shareholding of Promoter and Promoter Group 1410638.0 13.59
Aditya Arora Shareholding of Promoter and Promoter Group 1240091.0 11.95
Deepak Bansal Public Shareholding 1103174.0 10.63
Manohar Devabhaktuni Public Shareholding 516735.0 4.98
Dheeraj Kumar Lohia Public Shareholding 199458.0 1.92
Kadayam Ramnathan Bharat Public Shareholding 172100.0 1.66
Jani Bhasha Shaik Public Shareholding 150000.0 1.45
Anju Arora Shareholding of Promoter and Promoter Group 135634.0 1.31
Geeta Arora Shareholding of Promoter and Promoter Group 111500.0 1.07
Onkar Singh Public Shareholding 105700.0 1.02
Jugal Kishore Huf Shareholding of Promoter and Promoter Group 92350.0 0.89
Aarti Bajaj Shareholding of Promoter and Promoter Group 75.0 0.0

Kwality Pharmaceuticals Limite

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2017-01-05 0.6 Interim 2017-01-06 Equity shares
Ex-Date Ex-Bonus Ratio
2017-10-12 2017-10-11 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Kwality Pharmaceuticals Limite

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Kwality Pharmaceuticals Limite

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kwality Pharmaceuticals Ltd?

Answer Field

The share price of Kwality Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 511.

What is the Market Cap of Kwality Pharmaceuticals Ltd?

Answer Field

The market cap of Kwality Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 530.22 Cr. as of now.

What is the 52 Week High and Low of Kwality Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Kwality Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 545.00 and ₹ 248.00.

How to Buy Kwality Pharmaceuticals Ltd share?

Answer Field

You can trade in Kwality Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kwality Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 64.99%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader